All News Healios K.K.

Equities

4593

JP3835100003

Delayed Japan Exchange Other stock markets 09:23:59 05/07/2024 am IST			5-day change	1st Jan Change
177 ^JPY	+2.91%		-6.84%	+7.27%

20/06	Healios to Book $3 Million Upfront Payment as Sales Revenue in Q2 Following License Deal with Astellas Institute	MT
19/06	Healios K.K. Enters into License Agreement with Astellas Institute for Regenerative Medicine	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Healios to Book $3 Million Upfront Payment as Sales Revenue in Q2 Following License Deal with Astellas Institute	20/06	MT
Healios K.K. Enters into License Agreement with Astellas Institute for Regenerative Medicine	19/06	CI
Healios Enters Alliance, Bond Purchase Deal with Alfresa	06/06	MT
Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen	10/04	MT
Healios K.K. Enters into Joint Research Agreement with AND Medical Group	09/04	CI
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	04/04	MT
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	03/04	CI
Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data	26/02	MT
Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation	26/02	MT
Jefferies Adjusts Healios K.K.’s Price Target at 140 Yen From 170 Yen, Keeps at Hold	20/02	MT
Healios K.K. announced that it has received ¥2.2600715 billion in funding	09/02	CI
Healios K.K. and ProcellCure Inc. Announce Start of ARDS Clinical Trial in Japan	02/02	CI
Healios K.K. announced that it expects to receive ¥2.2600715 billion in funding	25/01	CI
Healios and ProcellCure Initiate Clinical Trial for ARDS Treatment	18/01	MT
Japanese Shares Finish Lower After Key Economic Data	18/01	MT
Healios K.K. and Its Wholly Owned Subsidiary ProcellCure Inc. Announce Submission of ARDS Clinical Trial Notification in Japan	18/01	CI
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	18/01	MT
Healios Secures LOI on Joint Research with AND	17/01	MT
Healios K.K. AND Medical Group Enter into A Letter of Intent for A Basic Agreement for Joint Research	16/01	CI
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	10/01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Healios K.K.

Equities

4593

JP3835100003

All News

Filters